NYSE:CORHealthcare
Assessing Cencora (COR) Valuation After Strong Returns And Premium P/E Multiple
Why Cencora is on investors’ radar today
Cencora (COR) has drawn attention after a solid year of positive total returns, along with reported annual revenue of US$321.3b and net income of US$1.6b, prompting investors to reassess how the stock is currently priced.
See our latest analysis for Cencora.
The current share price of US$352.47 sits against a 30 day share price return of 3.5% and a 90 day share price return of 5.9%, while the 1 year total shareholder return of 43.3% and 5 year total...